EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer
Although the TMPRSS2-ERG gene fusion is the most common alteration in human prostate cancer, its involvement in disease progression remains unclear. Here, the authors demonstrate that ERG is methylated by Enhancer of zest homolog 2 leading to enhanced transcriptional and oncogenic activity.
Guardado en:
Autores principales: | Marita Zoma, Laura Curti, Dheeraj Shinde, Domenico Albino, Abhishek Mitra, Jacopo Sgrignani, Sarah N. Mapelli, Giada Sandrini, Gianluca Civenni, Jessica Merulla, Giovanna Chiorino, Paolo Kunderfranco, Alessia Cacciatore, Aleksandra Kokanovic, Andrea Rinaldi, Andrea Cavalli, Carlo V. Catapano, Giuseppina M. Carbone |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e634d5688e6b4dc7aff08bbd1aa3f1c9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion gene.
por: Franclim R Ribeiro, et al.
Publicado: (2011) -
Acta Nº362
por: Banco Central de Chile
Publicado: (2019) -
Resolución 362(XVII): Evaluación de Guatemala = Resolution 362(XVII): The Guatemala appraisal
Publicado: (2014) -
Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer
por: Domenico Albino, et al.
Publicado: (2021) -
ERG transcriptional networks in primary acute leukemia cells implicate a role for ERG in deregulated kinase signaling.
por: Juliane Bock, et al.
Publicado: (2013)